MTF (10 mM) decreased the ratio of CD44+/CD133+ CSCs, in four colorectal cancer cell lines, whereas in four other colorectal cancer cell lines, MTF did not disturb the number of CSCs [126]. This evidence concerns the gene PROM1 and colorectal cancer.